APA (7th ed.) Citation

EWY, H., JB, C., A, A., AD, A., B, B., P, B., . . . D, Z. (2025). Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): A multi-partner/disciplinary working group perspective. RMD open, 11(4), . https://doi.org/10.1136/rmdopen-2025-005866

Chicago Style (17th ed.) Citation

EWY, Hsieh, et al. "Key Considerations for Advancing Chimeric Antigen Receptor (CAR) T-cell Therapy for Systemic Lupus Erythematosus (SLE): A Multi-partner/disciplinary Working Group Perspective." RMD Open 11, no. 4 (2025). https://doi.org/10.1136/rmdopen-2025-005866.

MLA (9th ed.) Citation

EWY, Hsieh, et al. "Key Considerations for Advancing Chimeric Antigen Receptor (CAR) T-cell Therapy for Systemic Lupus Erythematosus (SLE): A Multi-partner/disciplinary Working Group Perspective." RMD Open, vol. 11, no. 4, 2025, https://doi.org/10.1136/rmdopen-2025-005866.